When Is a Suboptimal Approach to Cancer Screening Better Than None?

RT @JournalofEthics: As @ramsedhom, MD and Bishal Gyawali (@oncology_bg), MD, PhD wrote in our Feb 2020 issue, mortality rates for breast c…

As @ramsedhom, MD and Bishal Gyawali (@oncology_bg), MD, PhD wrote in our Feb 2020 issue, mortality rates for breast cancer in particular are higher in regions where treatments are unavailable, unaffordable, or cost ineffective: https://t.co/MxLx3CsRYo

RT @JournalofEthics: When medical resources are scarce and standard, best-practice treatments are unavailable, when are suboptimal approach…

When medical resources are scarce and standard, best-practice treatments are unavailable, when are suboptimal approaches better than none at all? https://t.co/dMLmk8OWBP